COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASES CONTAINING CYANIDIN-3-O-(2-XYLOSYL) GLUCOSIDE

摘要

PURPOSE: A pharmaceutical composition containing cyanidin-3-O-(2''-xylosyl) glucoside is provided to suppress COX-2 and the transcription factors such as AP-1 and NF-kappaB. CONSTITUTION: A pharmaceutical composition for preventing and treating dermatitis contains 0.1-50 weight% of Acanthopanax sessiliforium extract as an active ingredient. The Acanthopanax sessiliforium extract is obtained by drying Acanthopanax sessiliforium at 30-40°C for 44-52 hours, pulverizing, adding 50-99% of ethanol to the dried powder and extracting for 20-28 hours. The concentration of Acanthopanax sessiliforium is 10uM-1mM. The dermatitis includes skin cancer or skin inflammation.